Markets:

Overview

News

Currencies

International

Treasuries

Inhibikase Therapeutics, Inc. - Common Stock (NQ:IKT)

1.685 +0.095 (+5.97%)

Streaming Delayed Price Updated: 1:49 PM EST, Dec 18, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Inhibikase Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

November 20, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

August 18, 2025

Via Benzinga

These stocks are moving in today's pre-market session ↗

August 18, 2025

Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 18, 2025

Via Benzinga

Inhibikase Posts Wider Loss in Q2 ↗

August 14, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 30, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

June 27, 2025

Via Benzinga

This PPG Industries Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday ↗

February 12, 2025

Via Benzinga

Stay updated with the stocks that are on the move in today's pre-market session. ↗

January 30, 2025

Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top gainers and losers in today's pre-market session.

Via Chartmill

Curious about the stocks that are showing activity after the closing bell on Wednesday? ↗

January 29, 2025

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

Via Chartmill

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 08, 2024

Via Benzinga

This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday ↗

November 08, 2024

Via Benzinga

Why Tesla Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket ↗

October 24, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 14, 2024

Via Benzinga

Dow Surges 350 Points; US Crude Oil Stocks Increase ↗

October 09, 2024

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 09, 2024

Via Benzinga

Crude Oil Edges Lower; US Wholesale Inventories Rise 0.1% In August ↗

October 09, 2024

Via Benzinga

Why Inhibikase Therapeutics (IKT) Stock Is Up 50% Today ↗

October 09, 2024

Inhibikase Therapeutics shares are trading higher by 50% during Wednesday's session. The company announced the pricing of an approximately $110 million private placement financing.

Via Benzinga

Dow Jumps Over 100 Points; Helen Of Troy Posts Upbeat Q2 Results ↗

October 09, 2024

Via Benzinga

Topics Stocks

IKT Stock Earnings: Inhibikase Therapeutics Beats EPS for Q2 2024 ↗

August 14, 2024

IKT stock results show that Inhibikase Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

IKT Stock Earnings: Inhibikase Therapeutics Beats EPS for Q1 2024 ↗

May 16, 2024

IKT stock results show that Inhibikase Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Why Vaxxinity Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

April 22, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

April 22, 2024

Via Benzinga

IKT Stock Earnings: Inhibikase Therapeutics Beats EPS for Q4 2023 ↗

March 27, 2024

IKT stock results show that Inhibikase Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

HC Wainwright & Co. Maintains Buy Rating for Inhibikase Therapeutics: Here's What You Need To Know ↗

March 05, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

January 26, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 25, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

January 24, 2024

Via Benzinga

Why Dermata Therapeutics Shares Are Trading Higher By Over 57%; Here Are 20 Stocks Moving Premarket ↗

January 05, 2024

Shares of Dermata Therapeutics, Inc. (NASDAQ: DRMA) rose sharply in pre-market trading after the company announced the issuance of a new patent in Japan for its DMT410 program for the treatment of...

Via Benzinga

Topics Intellectual Property

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 13, 2023

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Inhibikase Therapeutics, Inc. - Common Stock (NQ:IKT)

Headline News about Inhibikase Therapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today